(Q26851493)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23032601%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

Gene therapy through autologous transplantation of gene-modified hematopoietic stem cells (English)

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23032601%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23032601%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Sung-Yun Pai

series ordinal

2

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23032601%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Michel Sadelain

series ordinal

3

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23032601%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

language of work or name

1 reference

29 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23032601%20AND%20SRC:MED&resulttype=core&format=json

Biology of Blood and Marrow Transplantation

9 March 2020

published in

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23032601%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

19

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23032601%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

1 Suppl

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23032601%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

S64-9

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23032601%20AND%20SRC:MED&resulttype=core&format=json

Concise review: managing genotoxicity in the therapeutic modification of stem cells

9 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021

Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021

Thymic lymphoproliferative disease after successful correction of CD40 ligand deficiency by gene transfer in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021

Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021

Mechanism of reduction in titers from lentivirus vectors carrying large inserts in the 3'LTR.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021

Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021

Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021

Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021

Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021

Genome-wide high-throughput integrome analyses by nrLAM-PCR and next-generation sequencing

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021

Stem-cell transplantation for sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021

Gene therapy for immunodeficiency due to adenosine deaminase deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021

Allogeneic hematopoietic stem-cell transplantation for sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021

Efficacy of gene therapy for X-linked severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021

Stem-cell gene therapy for the Wiskott-Aldrich syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021

High-level beta-globin expression after retroviral transfer of locus activation region-containing human beta-globin gene derivatives into murine erythroleukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021

A method to sequence and quantify DNA integration for monitoring outcome in gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021

Genetic strategies for the treatment of sickle cell anaemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021

Strategy for a multicenter phase I clinical trial to evaluate globin gene transfer in beta-thalassemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021

Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021

Transcription start regions in the human genome are favored targets for MLV integration

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021

Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021

Long-term persistence of a polyclonal T cell repertoire after gene therapy for X-linked severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021

Hematopoietic stem cell gene therapy for adenosine deaminase-deficient severe combined immunodeficiency leads to long-term immunological recovery and metabolic correction

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021

Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021

The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021

Lentiviral vector integration in the human genome induces alternative splicing and generates aberrant transcripts

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021

Correction of a mouse model of sickle cell disease: lentiviral/antisickling beta-globin gene transduction of unmobilized, purified hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021

Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021

Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021

Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood?

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021

Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021

Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBMT.2012.09.021

7 January 2021